Defining Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease. The Patient-Centered Experience

Medical Clinics of North America

Volumn 96, Issue 4, 2012, Pages 767-787

  Singer, Jonathan P ^a   Yusen, Roger D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Disability; Health related quality of life; Patient reported outcomes; Utility

Indexed keywords

AZITHROMYCIN; CARBON MONOXIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; MACROLIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; TIOTROPRIUM; UNCLASSIFIED DRUG;

ANXIETY; ARTERIAL GAS; ASTHMA; BASELINE DYSPNEA INDEX; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY DISEASE QUESTIONNAIRE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSPNEA; EUROQOL; EXERCISE; FATIGUE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEALTH UTILITY INDEX; HEALTH UTILITY INDEX MARK 3; HUMAN; INSOMNIA; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; MEDICAL EDUCATION; MENTAL COMPONENT SUMMARY; MENTAL HEALTH; META ANALYSIS (TOPIC); MINIMUM IMPORTANT DIFFERENCE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MORTALITY; MULTICENTER STUDY (TOPIC); MUSCULOSKELETAL DISEASE; NOTTINGHAM HEALTH PROFILE; OUTCOME ASSESSMENT; OXYGEN THERAPY; PAIN; PATIENT PREFERENCE; PHYSICAL COMPONENT SUMMARY; POST HOC ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOMETRY; PULMONARY REHABILITATION; QUALITY ADJUSTED LIFE YEAR; QUALITY OF WELL BEING SCALE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT FORM 36; SHORTNESS OF BREATH QUESTIONNAIRE; SICKNESS IMPACT PROFILE; SLEEP; SOCIAL INTERACTION; ST GEORGE'S RESPIRATORY QUESTIONNAIRE; STATISTICAL MODEL; TRANSITIONAL DYSPNEA INDEX; UC SAN DIEGO SHORTNESS OF BREATH QUESTIONNAIRE; VISUAL ANALOG SCALE;

DISEASE PROGRESSION; HEALTH STATUS INDICATORS; HUMANS; MODELS, BIOLOGICAL; PATIENT PREFERENCE; PATIENT-CENTERED CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84863842636     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.05.005     Document Type: Review

References (97)

1. World Health Report 2000, World Health Organization, Geneva (Switzerland).
2. Murphy S.L., Xu J., Kochanek K. Deaths: preliminary data for 2010. National vital statistics reports 2012, National Center for Health Statistics, Hyattsville (MD).
3. Anthonisen N.R., Connett J.E., Kiley J.P., et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994, 272:1497-1505.
4. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980, 93:391-398.
5. Fishman A., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348:2059-2073.
6. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
7. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006, 4:79.
8. Yusen R. What outcomes should be measured in patients with COPD?. Chest 2001, 119:327-328.
9. Doward L.C., McKenna S.P. Defining patient-reported outcomes. Value Health 2004, 7(Suppl 1):S4-S8.
10. Fletcher C.M., Elmes P.C., Fairbairn A.S., et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959, 2:257-266.
11. Mahler D.A., Weinberg D.H., Wells C.K., et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758.
12. Eakin E.G., Resnikoff P.M., Prewitt L.M., et al. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998, 113:619-624.
13. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
14. Bergner M., Bobbitt R.A., Carter W.B., et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981, 19:787-805.
15. Jones P.W., Quirk F.H., Baveystock C.M., et al. A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
16. Curtis J.R., Martin D.P., Martin T.R. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here?. Am J Respir Crit Care Med 1997, 156:1032-1039.
17. Measuring quality of life, 1997. Available at: Accessed May 9, 2012. http://www.who.int/mental_health/media/68.pdf.
18. McDowell I. Measuring health: a guide to rating scales and questionnaires 2006, Oxford University Press, New York. 3rd edition.
19. Weinstein M.C., Fineber H.V., Elstein A.S., et al. Clinical decision analysis 1980, WB Saunders, Philadelphia.
20. Sox H.C., Blatt M.A., Higgins M.C., et al. Medical decision making 1988, Butterworth, Boston.
21. Yusen R.D. Technology and outcomes assessment in lung transplantation. Proc Am Thorac Soc 2009, 6:128-136.
22. Yusen R.D. Lung transplantation outcomes: the importance and inadequacies of assessing survival. Am J Transplant 2009, 9:1493-1494.
23. Yusen R.D. Survival and quality of life of patients undergoing lung transplant. Clin Chest Med 2011, 32:253-264.
24. Weinstein M.C., Pliskin J.S., Stason W.B. Coronary artery bypass surgery. Decision and policy analysis. Costs, risks, and benefits of surgery 1977, 342-371. Oxford University Press, New York. J.P. Bunker, B.A. Barnes, F. Mosteller (Eds.).
25. Gafni A. The Standard Gamble method: what is being measured and how it is interpreted. Health Serv Res 1994, 29:207-224.
26. Anderson J.P., Kaplan R.M., Berry C.C., et al. Interday reliability of function assessment for a health status measure. The quality of well-being scale. Med Care 1989, 27:1076-1083.
27. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208.
28. Furlong W.J., Feeny D.H., Torrance G.W., et al. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33:375-384.
29. Dolan P. Whose preferences count?. Med Decis Making 1999, 19:482-486.
30. Nord E., Pinto J.L., Richardson J., et al. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999, 8:25-39.
31. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996, 276:1253-1258.
32. Blough D.K., Ramsey S., Sullivan S.D., et al. The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery. Health Econ 2009, 18:91-101.
33. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
34. Martinez F.J., Foster G., Curtis J.L., et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006, 173:1326-1334.
35. Puhan M.A., Garcia-Aymerich J., Frey M., et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009, 374:704-711.
36. Eisner M.D., Trupin L., Katz P.P., et al. Development and validation of a survey-based COPD Severity Score. Chest 2005, 127:1890-1897.
37. Pickard A.S., Yang Y., Lee T.A. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011, 9:26.
38. Stahl E., Lindberg A., Jansson S.A., et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005, 3:56.
39. Hajiro T., Nishimura K., Tsukino M., et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999, 116:1632-1637.
40. van Schayck C.P., Rutten-van Molken M.P., van Doorslaer E.K., et al. Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life. Chest 1992, 102:1384-1391.
41. Prigatano G.P., Wright E.C., Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984, 144:1613-1619.
42. Eisner M.D., Blanc P.D., Yelin E.H., et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008, 121:789-796.
43. Shoup R., Dalsky G., Warner S., et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 1997, 10:1576-1580.
44. Singer J., Yelin E.H., Katz P.P., et al. Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 2011, 31:111-119.
45. Gonzalez E., Herrejon A., Inchaurraga I., et al. Determinants of health-related quality of life in patients with pulmonary emphysema. Respir Med 2005, 99:638-644.
46. Katsura H., Yamada K., Wakabayashi R., et al. The impact of dyspnoea and leg fatigue during exercise on health-related quality of life in patients with COPD. Respirology 2005, 10:485-490.
47. van Manen J.G., Bindels P.J., Dekker E.W., et al. Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med 2001, 95:496-504.
48. Wijnhoven H.A., Kriegsman D.M., Hesselink A.E., et al. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med 2003, 97:468-475.
49. van Manen J.G., Bindels P.J., Dekker F.W., et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol 2003, 56:1177-1184.
50. van Ede L., Yzermans C.J., Brouwer H.J. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999, 54:688-692.
51. Lacasse Y., Rousseau L., Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001, 21:80-86.
52. Yohannes A.M., Baldwin R.C., Connolly M.J. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000, 15:1090-1096.
53. Kunik M.E., Roundy K., Veazey C., et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005, 127:1205-1211.
54. Wagena E.J., Kant I., Huibers M.J., et al. Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes. Eur J Epidemiol 2004, 19:147-153.
55. Cinciripini P.M., Wetter D.W., Fouladi R.T., et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol 2003, 71:292-301.
56. Yellowlees P.M., Alpers J.H., Bowden J.J., et al. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 1987, 146:305-307.
57. Clary G.L., Palmer S.M., Doraiswamy P.M. Mood disorders and chronic obstructive pulmonary disease: current research and future needs. Curr Psychiatry Rep 2002, 4:213-221.
58. Almagro P., Calbo E., Ochoa de Echaguen A., et al. Mortality after hospitalization for COPD. Chest 2002, 121:1441-1448.
59. Andersson I., Johansson K., Larsson S., et al. Long-term oxygen therapy and quality of life in elderly patients hospitalised due to severe exacerbation of COPD. A 1 year follow-up study. Respir Med 2002, 96:944-949.
60. Davies L., Wilkinson M., Bonner S., et al. " Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000, 321:1265-1268.
61. Spencer S., Jones P.W. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003, 58:589-593.
62. Doll H., Grey-Amante P., Duprat-Lomon I., et al. Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. Respir Med 2002, 96:39-51.
63. Osman I.M., Godden D.J., Friend J.A., et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997, 52:67-71.
64. Singer J.P., Blanc P.D., Iribarren C., et al. Health-related quality of life predicts severe exacerbations of COPD. Am J Respir Crit Care Med 2009, 179:A1519.
65. Domingo-Salvany A., Lamarca R., Ferrer M., et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:680-685.
66. Marin J.M., Cote C.G., Diaz O., et al. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med 2011, 105:916-921.
67. Ong K.C., Earnest A., Lu S.J. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005, 128:3810-3816.
68. Martinez F.J., Han M.K., Andrei A.C., et al. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008, 178:491-499.
69. Omachi T.A., Yelin E.H., Katz P.P., et al. The COPD Severity Score: a dynamic prediction tool for health-care utilization. COPD 2008, 5:339-346.
70. Burge P.S., Calverley P.M., Jones P.W., et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000, 320:1297-1303.
71. Brusasco V., Hodder R., Miravitlles M., et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003, 58:399-404.
72. Donohue J.F., van Noord J.A., Bateman E.D., et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002, 122:47-55.
73. Vincken W., van Noord J.A., Greefhorst A.P., et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002, 19:209-216.
74. Tashkin D.P., Celli B., Senn S., et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
75. Calverley P., Pauwels R., Vestbo J., et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003, 361:449-456.
76. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789.
77. Albert R.K., Connett J., Bailey W.C., et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011, 365:689-698.
78. Eaton T., Garrett J.E., Young P., et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002, 20:306-312.
79. Lacasse Y., Goldstein R., Lasserson T.J., et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, 3. CD003793.
80. Nishiyama O., Taniguchi H., Kondoh Y., et al. Factors in maintaining long-term improvements in health-related quality of life after pulmonary rehabilitation for COPD. Qual Life Res 2005, 14:2315-2321.
81. Seemungal T.A., Wedzicha J.A. Integrated care: a new model for COPD management?. Eur Respir J 2006, 28:4-6.
82. Bourbeau J., Julien M., Maltais F., et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003, 163:585-591.
83. Monninkhof E., van der Valk P., van der Palen J., et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003, 22:815-820.
84. Effing T., Monninkhof E.M., van der Valk P.D., et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007, 4:CD002990.
85. Chavannes N.H., Grijsen M., van den Akker M., et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J 2009, 18:171-176.
86. Yusen R.D., Littenberg B. Integrating survival and quality of life data in clinical trials of lung disease: the case of lung volume reduction surgery. Chest 2005, 127:1094-1096.
87. Ramsey S.D., Berry K., Etzioni R., et al. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003, 348:2092-2102.
88. Naunheim K.S., Wood D.E., Mohsenifar Z., et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006, 82:431-443.
89. Benzo R., Farrell M.H., Chang C.C., et al. Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med 2009, 180:239-246.
90. Orens J.B., Estenne M., Arcasoy S., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006, 25:745-755.
91. Limbos M.M., Joyce D.P., Chan C.K., et al. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000, 118:408-416.
92. Rodrigue J.R., Baz M.A., Kanasky W.F., et al. Does lung transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant 2005, 24:755-763.
93. Smeritschnig B., Jaksch P., Kocher A., et al. Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant 2005, 24:474-480.
94. Eskander A., Waddell T.K., Faughnan M.E., et al. BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation. J Heart Lung Transplant 2011, 30:1334-1341.
95. Mittler B., Brown K., Yusen R.D. Impact of lung transplantation in the U.S. Lung Allocation Score system on quality of life in patients with chronic obstructive pulmonary disease. J Heart Lung Transplant 2012, 31:S27.
96. Yusen R.D., Brown K.L., Habrock T.E., et al. The impact of lung transplantation on quality of life in patients with COPD. J Heart Lung Transplant 2005, 24:S156-S157.
97. Gerbase M.W., Spiliopoulos A., Rochat T., et al. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005, 128:1371-1378.